# Kaleido Biosciences, Inc. (KLDO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/KLDO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2021 | $ 1.31M | $ -109.29M | $ -92.98M | $ 21.69M | $ 10.61M |
| 2020 | $ 1.24M | $ -103.26M | $ -83.50M | $ 21.01M | $ 20.50M |
| 2019 | $ 0 | $ -111.43M | $ -102.46M | $ 20.46M | $ 48.88M |
| 2018 | $ 0 | $ -81.54M | $ -65.13M | $ 14.92M | $ 58.20M |
| 2017 | $ 0 | $ -13.68M | $ -12.04M | $ 14.91M | $ -43.68M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 2.05 |
| Liabilities / Eq | 3.73 |
| Current Ratio | 1.43 |

## Other views

- [Metrics](https://sponda.capital/en/KLDO.md)
- [Charts](https://sponda.capital/en/KLDO/charts.md)
- [Compare](https://sponda.capital/en/KLDO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.